Literature DB >> 7818653

Hazards of reducing cholesterol.

C Lines.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7818653      PMCID： PMC2542751          DOI： 10.1136/bmj.309.6953.541

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Ischemic heart disease and cholesterol. Safety of cholesterol reduction remains in doubt.

Authors:  M F Muldoon; S B Manuck
Journal:  BMJ       Date:  1994-04-23

2.  Assessing possible hazards of reducing serum cholesterol.

Authors:  M R Law; S G Thompson; N J Wald
Journal:  BMJ       Date:  1994-02-05

3.  Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin.

Authors:  C A Dujovne; A N Chremos; J L Pool; H Schnaper; R H Bradford; C L Shear; J Higgins; M Downton; F A Franklin; D T Nash
Journal:  Am J Med       Date:  1991-07-31       Impact factor: 4.965
  3 in total
  2 in total

1.  Having too much evidence (depression, suicide, and low serum cholesterol)

Authors:  M Law
Journal:  BMJ       Date:  1996-09-14

Review 2.  The "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst.

Authors:  Nusrat Shafiq; Samir Malhotra; Promila Pandhi; Anil Grover
Journal:  J Negat Results Biomed       Date:  2005-03-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.